Autonomic and Cardiovascular Recovery After the Acute Use of Resveratrol in Overweight and Obesity Individuals

Launched by TAISY CINTHIA FERRO CAVALCANTE · Aug 27, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a supplement called resveratrol on people who are overweight or have grade I obesity. Resveratrol is a natural compound found in certain foods, and researchers want to see if taking it can help improve heart health and the way the body regulates its metabolism. The goal is to find out if resveratrol can help reduce the risk of health problems related to obesity and lower healthcare costs.

To participate in this study, individuals must be overweight or have grade I obesity. However, those with serious heart or breathing issues, neurological disorders, muscle injuries, or other conditions that might interfere with the study will not be eligible. If someone qualifies, they can expect to join a research group that will monitor their health and wellbeing throughout the trial, helping to provide valuable information about how resveratrol might benefit people with weight-related health concerns.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - Individuals with overweight and obesity grade I
• Exclusion Criteria:
• • Cardiorespiratory disorders
• • Neurological disorders
• • skeletal muscle injury
• • Known impairments that prevent the subject from performing the procedures.